+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of technetium-99m tetrofosmin an thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease



Comparison of technetium-99m tetrofosmin an thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease



Journal of the American College of Cardiology 31(2): 331-337



Objectives. We compared dipyridamole technetium-99m (Tc-99m) tetrofosmin and thallium-201 (Tl-201) single-photon emission computed tomographic (SPECT) imaging with respect to the detection rate of perfusion abnormalities in 26 patients with angiographic coronary artery disease (CAD). Background. Experimental studies have shown that myocardial extraction of Tc-99m tetrofosmin is lower than that of Tl-201 at high flow rates, resulting in less severe defects with vasodilator stress. It is uncertain whether this results in a lower sensitivity than Tl-201 for detecting coronary stenoses with vasodilator stress in patients. Methods. Twenty-six patients with CAD underwent both dipyridamole TI-201 and Tc-99m tetrofosmin SPECT. Tomographic images were scored for initial defects and the presence of reversibility. Defect magnitude was computer quantitated. Results. Of the 26 patients, 25 had defects on both Tl-201 and Tc-99m tetrofosmin SPECT images. Of 340 segments analyzed, 102 had defects by Tl-201 and 92 by Tc-99m tetrofosmin (p = NS). Whereas Tl-201 detected 27 fixed defects in 12 patients, Tc-99m tetrofosmin identified 37 fixed defects in 14 patients (p = NS). In contrast Tl-201 identified more reversible and partially reversible defects than did Tc-99m tetrofosmin (89 vs. 55, p = 0.002). The average defect magnitude (percent normal) was similar for defects concordantly graded as fixed (38 +- 3.0% for TI-201 vs. 42 +- 4% (mean +- SEM) for Tc-99m tetrofosmin, p = NS). The average defect magnitude for defects concordantly graded as completely reversible was significantly more severe on Tl-201 than on Tc-99m tetrofosmin (49 +- 3% vs. 58 +- 3%) SPECT images. A significantly greater defect magnitude for Tl-201 was also found for defects concordantly classified as partly reversible (30 +- 411/c for Tl-201 vs. 45 +- 5% for Tc-99m tetrofosmin). Conclusions. With dipyridamole stress, 1) at least one defect was seen on both Tl-201 and Tc-99m tetrofosmin SPECT images; 2) Tc-99m tetrofosmin SPECT identified fewer reversible defects than did Tl-201, but showed a similar number of fixed defects; 3) the magnitude of reversible defects seen on Tc-99m tetrofosmin images was less, whereas fixed defects were similar for both tracers; 4) reversible defects seen on Tl-201 and not on Tc-99m tetrofosmin SPECT images were predominantly regions perfused by mild coronary stenoses.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008361456

Download citation: RISBibTeXText

PMID: 9462576


Related references

Comparison of defect size between thallium-201 and technetium-99m tetrofosmin myocardial single-photon emission computed tomography in patients with single-vessel coronary artery disease. American Journal Of Cardiology. 77(5): 350-354, 1996

Comparison of dipyridamole Thallium-201 with dipyridamole technetium-99m Tetrofosmin single photon emission computed tomography imaging in patients with angiographically confirmed coronary artery disease. Circulation 94(8 Suppl. ): I301, 1996

Prognostic value of technetium-99m-tetrofosmin stress myocardial perfusion single-photon emission computed tomography in patients with suspected or known coronary artery disease. Journal of Nuclear Medicine 44(5 Suppl.): 3P, 2003

Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single-photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs. Journal of the American College of Cardiology 31(7): 1540-1546, 1998

Comparison of single-photon emission computed tomographic (SPECT) myocardial perfusion imaging with thallium-201 and technetium-99m sestamibi in dogs. Journal of the American College of Cardiology 20(7): 1612-1625, 1992

Comparison of technetium 99m-tetrofosmin and thallium-201 single photon emission computed tomographic imaging for the assessment of viable myocardium in patients with left ventricular dysfunction. Journal of Nuclear Cardiology 5(1): 56-63, 1998

Myocardial technetium 99m-labeled sestamibi single-photon emission computed tomographic imaging in the detection of coronary artery disease: comparison between early (15 minutes) and delayed (60 minutes) imaging. Journal of Nuclear Cardiology 1(5 Pt 1): 441-448, 1994

Usefulness of stress gated technetium-99m single photon emission computed tomographic myocardial perfusion imaging for the prediction of cardiac death in patients with moderate to severe left ventricular systolic dysfunction and suspected coronary artery disease. American Journal of Cardiology 109(1): 26-30, 2012

Defect extent and severity are underestimated with dobutamine stress using technetium-99m tetrofosmin single-photon emission computed tomographic myocardial perfusion imaging. Journal of the American College of Cardiology 33(2 Suppl. A): 418A, 1999

Calcified occlusion of the right coronary artery in Kawasaki disease: evidence of myocardial ischaemia using cardiac technetium-99m-tetrofosmin perfusion single-photon emission computed tomography. Archives of Disease in Childhood 91(11): 926-928, 2006

Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease. Journal of Nuclear Cardiology 5(3): 265-274, 1998

Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. American Journal of Cardiology 90(8): 827-832, 2002

Incremental prognostic power of single-photon emission computed tomographic myocardial perfusion imaging in patients with known or suspected coronary artery disease. American Journal of Cardiology 95(2): 182-188, 2005

Relationship between lung-to-heart uptake ratio of technetium-99m-tetrofosmin during exercise myocardial single photon emission computed tomographic imaging and the number of diseased coronary arteries in patients with effort angina pectoris without myocardial infarction. Journal of Cardiology 43(4): 165-171, 2004

Comparison of the predictive value of exercise-induced ST depression versus exercise technetium-99m sestamibi single-photon emission computed tomographic imaging for detection of coronary artery disease in patients with left ventricular hypertrophy. American Journal of Cardiology 93(3): 333-336, 2004